XML 183 R106.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Equity (Share-based Payments to Employees, Restricted Shares) (Details) - Restricted shares [Member] shares in Thousands, $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2023 USD ($) shares
Icls Directors Excluding Icls Ceo And Chairman Of Bod [Member] | January 10, 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Number Of Instruments | shares | 137
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Additional information | The value of the restricted shares was determined according to the closing price on the TASE on the most recent trading day preceding the grant date (the approval date of the BOD and/or the approval date of the General Meeting).
Officers and senior employees [Member] | March 6 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Number Of Instruments | shares | 1,726
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Instrument terms | An issuance for no consideration, under the amended 2014 Equity Compensation Plan.
Additional information | The value of the restricted shares was determined according to the closing price on the TASE on the most recent trading day preceding the grant date (the approval date of the BOD and/or the approval date of the General Meeting).
Chief Executive Officers [Member] | May 14, 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Number Of Instruments | shares | 121
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Instrument terms | An issuance for no consideration, under the amended 2014 Equity Compensation Plan.
Additional information | The value of the restricted shares was determined according to the closing price on the TASE on the most recent trading day preceding the grant date (the approval date of the BOD and/or the approval date of the General Meeting).
Former Chairman Board Of Directors [Member] | August 20, 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Number Of Instruments | shares | 47
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date
Instrument terms | An issuance for no consideration, under the amended 2014 Equity Compensation Plan.
Additional information | The value of the restricted shares was determined according to the closing price on the TASE on the most recent trading day preceding the grant date (the approval date of the BOD and/or the approval date of the General Meeting).
Icl Directors Excluding Directors Who Are Officers Or Directors Of Il Corp Ltd Member | January 10, 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Fair value at the grant date (Million) | $ | $ 0.6
Icl Directors Excluding Directors Who Are Officers Or Directors Of Il Corp Ltd Member | March 6 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Fair value at the grant date (Million) | $ | 8.0
Icl Directors Excluding Directors Who Are Officers Or Directors Of Il Corp Ltd Member | May 14, 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Fair value at the grant date (Million) | $ | 0.6
Icl Directors Excluding Directors Who Are Officers Or Directors Of Il Corp Ltd Member | August 20, 2018 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Fair value at the grant date (Million) | $ | $ 0.2
Icl Directors Excluding Directors Who Are Officers Or Directors Of Il Corp Ltd Member | April 23, 2020 [Member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Number Of Instruments | shares | 177
Vesting conditions | 3 equal tranches: (1) one third on January 1, 2021 (2) one third on January 1, 2022 (3) one third on January 1,2023
Instrument terms | An issuance for no consideration, under the amended 2014 Equity Compensation Plan.
Additional information | The value of the restricted shares was determined according to the closing price on the TASE on the most recent trading day preceding the Grant Date (the approval date of the annual General Meeting of shareholders).
Fair value at the grant date (Million) | $ | $ 0.6

X
- References No definition available. + Details
Name: | icl_NumberOfInstruments
Namespace Prefix: | icl_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the method of settlement (for example, whether in cash or equity) for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of a share-based payment arrangement that existed at any time during the reporting period. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=icl_RestrictedSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_IclsDirectorsExcludingIclsCeoAndChairmanOfBodMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_January102018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_OfficersAndSeniorEmployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_March62018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_ChiefExecutiveOfficersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_May142018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_FormerChairmanBoardOfDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_August202018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_IclDirectorsExcludingDirectorsWhoAreOfficersOrDirectorsOfIlCorpLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_April232020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |